Key Marketed Proprietary Products > PARAGARD®

Duramed's PARAGARD® T 380A (Intrauterine Copper Contraceptive) provides women with a long-term, reversible, non-hormonal contraceptive option. It is more than 99% effective at preventing pregnancy and is the only IUC approved for up to 10 years of continuous use.

PARAGARD® was approved in 1984 and has been marketed in the United States since 1988. We believe that IUCs represent an underutilized contraceptive option for women in the United States, and Duramed is well-positioned to grow this category through professional education and marketing. Duramed acquired FEI Women's Health, LLC and the PARAGARD® IUC in November 2005 and promotes the product to physicians and health care practitioners using its Specialty and Institutional Sales Force.

Important Safety Information

PARAGARD® does not protect against HIV/AIDS or other sexually transmitted diseases. A woman must not use PARAGARD® if she currently has acute Pelvic Inflammatory Disease (PID) or engages in current behavior suggesting a high risk for PID. PARAGARD® is also not an option for women who might be pregnant, have had a post-pregnancy or post-abortion uterine infection in the past three months, have a uterus that is abnormally shaped inside, have cancer of the uterus or cervix, have an infection in the cervix, have unexplained bleeding of the vagina, have an allergy to any component of PARAGARD®, or have Wilson's disease.

The most common side effects of PARAGARD® are heavier and longer periods for a few months after placement; some women have spotting between periods. For most women, this typically subsides after a few months. If you ever miss a period, call your healthcare professional without delay, as you might be pregnant.

Some possible serious complications that have been associated with intrauterine contraceptives, including PARAGARD®, are pelvic inflammatory disease (PID), perforation of the uterus, expulsion (where the contraceptive falls completely or partially out of the uterus) and difficult removals.

Please see complete prescribing information at www.PARAGARD.com..

Click HERE to download Patient Information Brochure.

Click HERE to download Prescribing Information Brochure.

Click HERE to be taken to the product guide website.